News

A retrospective cohort analysis of patients in Finland show a notable overlap of the 2 forms of vision loss.

A comparative trial of biologic agents suggest IL-17A inhibitors may more significantly improve skin clearance in comorbid patients.

An analysis of the change from preoperative to final BCVA showed no difference between the deferred and immediate surgery subgroups.

TRD episodes resulted in more inpatient bed-days and lost workdays compared to non-TRD episodes.

The indication expands the marketed use of the atypical antipsychotic drug to be used with antidepressants in adult patients.

SB11 and ranibizumab appeared to have comparable immunogenicity and safety profiles in a post-hoc analysis of a phase 3 equivalence trial.

Almost 4 years since the beginning of the pandemic, continuous research efforts have begun to paint a better picture of the impact the virus has on the brain and the central nervous system.

This newly-approved monoclonal antibody was developed as a citrate-free formulation of adalimumab.

The receipt of DAA treatment within 1 year was 7% for patients entering the cohort in 2014, compared to 33% in 2015, 53% in 2016, and 56% in 2017.

New research into bimekizumab for psoriatic arthritis suggests the treatment to be effective for joint and skin improvements at 16 weeks.

With several newly approved therapies hitting the market and an overflowing pipeline, the FDA has stepped in to help keep the burgeoning world of biotech on track.

An interview with Karan Lal, DO, regarding skincare product allergens, misdiagnosis of allergic contact dermatitis, and more.

A longitudinal, observational study shows chronic inflammatory disease patient scores for anxiety and sleep disturbance were bettered following doses of a SARS-CoV-2 vaccine.

An economic analysis of a clinical sleep intervention suggests it may provide a step toward improved health equity.

Previous studies aimed at understanding the association between intermittent hypoxia and impaired vigilance in patients with OSA provided conflicting results.

New research indicated that the effects of sleep and physical activity deficiencies in low income youth were found to have an association with maladjustment.

Sleep expert Dr. Sara Mednick says one of the major goals to improve sleep health isn't simply for health benefits, but because it's essential to repair the daily buildup of toxins that accumulate during each wake period.

The total duration of sleep increased from 9 hours 8 minutes prior to the pandemic to 9 hours 54 minutes during school closures in Taiwan.

A multiple linear regression analysis reported a significant, positive association between sleep quality and number of CVD risk factors.

Both shorter and longer sleep duration were associated with fewer academic enables and lower academic skills and math grades.

New research found a correlation between actigraphy determined night-to-night sleep regularity and glycemic control over a 249 person-days CGM period.

Reflections on a century's worth of developments toward a major breakthrough in T1D this year.

The investigators also found an increase in the proportions of monthly hospitalizations during the pandemic for a number of disorders, including anxiety, depression, and suicidality or self-injury.

The treatment rate decreased from 64.8% to 61.2% after 2018.

Researchers have developed an automated hair loss measurement system for alopecia patients to track hair loss.

People with diabetes were 11% more likely to develop glaucoma and/or OHT, and individuals with glaucoma and/or OHT were 12% more likely to develop diabetic retinopathy.

Expert Stephanie Guarino, MD, MSHP, shares her plan for the future of pain management specifically for sickle cell disease is based on results from a series of studies.

This year saw 4 new FDA approvals for the chronic condition. But dermatologists are still not satisfied.

The most common thrombophilia types were heterozygosity for factor V Leiden, prothrombin 20210A mutation, and protein S deficiency.

More research presented by Dr. Stephanie Guarino resulted in a recommended guideline designed for investigating sickle cell disease pain to standardize and enhance the quality of data.